Logo image of AGS.BR

AGEAS (AGS.BR) Stock Fundamental Analysis

EBR:AGS - Euronext Brussels - BE0974264930 - Common Stock - Currency: EUR

62.15  +0.45 (+0.73%)

Fundamental Rating

3

Overall AGS gets a fundamental rating of 3 out of 10. We evaluated AGS against 38 industry peers in the Insurance industry. While AGS is still in line with the averages on profitability rating, there are concerns on its financial health. AGS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year AGS was profitable.
AGS had a positive operating cash flow in the past year.
Each year in the past 5 years AGS has been profitable.
The reported operating cash flow has been mixed in the past 5 years: AGS reported negative operating cash flow in multiple years.
AGS.BR Yearly Net Income VS EBIT VS OCF VS FCFAGS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B

1.2 Ratios

AGS has a Return On Assets of 1.14%. This is comparable to the rest of the industry: AGS outperforms 50.00% of its industry peers.
AGS has a Return On Equity (14.42%) which is in line with its industry peers.
Industry RankSector Rank
ROA 1.14%
ROE 14.42%
ROIC N/A
ROA(3y)1.08%
ROA(5y)1.01%
ROE(3y)14.33%
ROE(5y)11.99%
ROIC(3y)N/A
ROIC(5y)N/A
AGS.BR Yearly ROA, ROE, ROICAGS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 12.55%, AGS is in the better half of the industry, outperforming 76.32% of the companies in the same industry.
AGS's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 15.03%, AGS is doing good in the industry, outperforming 73.68% of the companies in the same industry.
AGS's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.03%
PM (TTM) 12.55%
GM N/A
OM growth 3Y20.52%
OM growth 5Y15.89%
PM growth 3Y24.5%
PM growth 5Y12.46%
GM growth 3YN/A
GM growth 5YN/A
AGS.BR Yearly Profit, Operating, Gross MarginsAGS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1

2. Health

2.1 Basic Checks

AGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
AGS has less shares outstanding than it did 1 year ago.
The number of shares outstanding for AGS has been reduced compared to 5 years ago.
The debt/assets ratio for AGS is higher compared to a year ago.
AGS.BR Yearly Shares OutstandingAGS.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AGS.BR Yearly Total Debt VS Total AssetsAGS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

AGS has a debt to FCF ratio of 7.40. This is a slightly negative value and a sign of low solvency as AGS would need 7.40 years to pay back of all of its debts.
AGS has a worse Debt to FCF ratio (7.40) than 65.79% of its industry peers.
AGS has a Debt/Equity ratio of 0.61. This is a neutral value indicating AGS is somewhat dependend on debt financing.
The Debt to Equity ratio of AGS (0.61) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 7.4
Altman-Z N/A
ROIC/WACCN/A
WACC7.04%
AGS.BR Yearly LT Debt VS Equity VS FCFAGS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
AGS.BR Yearly Current Assets VS Current LiabilitesAGS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 17.42% over the past year.
Measured over the past 5 years, AGS shows a small growth in Earnings Per Share. The EPS has been growing by 3.68% on average per year.
Looking at the last year, AGS shows a quite strong growth in Revenue. The Revenue has grown by 13.36% in the last year.
AGS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.69% yearly.
EPS 1Y (TTM)17.42%
EPS 3Y10.44%
EPS 5Y3.68%
EPS Q2Q%13.2%
Revenue 1Y (TTM)13.36%
Revenue growth 3Y-11.82%
Revenue growth 5Y-8.69%
Sales Q2Q%12.18%

3.2 Future

AGS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.75% yearly.
Based on estimates for the next years, AGS will show a small growth in Revenue. The Revenue will grow by 2.66% on average per year.
EPS Next Y6.46%
EPS Next 2Y7.75%
EPS Next 3Y7.49%
EPS Next 5Y2.75%
Revenue Next Year10.24%
Revenue Next 2Y6.98%
Revenue Next 3Y6.13%
Revenue Next 5Y2.66%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AGS.BR Yearly Revenue VS EstimatesAGS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B
AGS.BR Yearly EPS VS EstimatesAGS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.21, which indicates a very decent valuation of AGS.
Compared to the rest of the industry, the Price/Earnings ratio of AGS indicates a rather cheap valuation: AGS is cheaper than 86.84% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of AGS to the average of the S&P500 Index (26.93), we can say AGS is valued rather cheaply.
AGS is valuated reasonably with a Price/Forward Earnings ratio of 8.61.
84.21% of the companies in the same industry are more expensive than AGS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 35.31. AGS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.21
Fwd PE 8.61
AGS.BR Price Earnings VS Forward Price EarningsAGS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AGS is valued a bit cheaper than the industry average as 73.68% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, AGS is valued a bit more expensive than the industry average as 68.42% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 19.26
EV/EBITDA 9.06
AGS.BR Per share dataAGS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.58
PEG (5Y)2.78
EPS Next 2Y7.75%
EPS Next 3Y7.49%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.01%, AGS is a good candidate for dividend investing.
AGS's Dividend Yield is comparable with the industry average which is at 4.28.
Compared to an average S&P500 Dividend Yield of 2.39, AGS pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.01%

5.2 History

On average, the dividend of AGS grows each year by 8.13%, which is quite nice.
Dividend Growth(5Y)8.13%
Div Incr Years1
Div Non Decr Years1
AGS.BR Yearly Dividends per shareAGS.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

52.24% of the earnings are spent on dividend by AGS. This is a bit on the high side, but may be sustainable.
AGS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP52.24%
EPS Next 2Y7.75%
EPS Next 3Y7.49%
AGS.BR Yearly Income VS Free CF VS DividendAGS.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B -1.5B
AGS.BR Dividend Payout.AGS.BR Dividend Payout, showing the Payout Ratio.AGS.BR Dividend Payout.PayoutRetained Earnings

AGEAS

EBR:AGS (8/14/2025, 7:00:00 PM)

62.15

+0.45 (+0.73%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)08-27 2025-08-27
Inst Owners56.55%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap12.36B
Analysts76
Price Target56.76 (-8.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.01%
Yearly Dividend3.19
Dividend Growth(5Y)8.13%
DP52.24%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.3%
PT rev (3m)1.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.01%
Revenue NY rev (3m)1.01%
Valuation
Industry RankSector Rank
PE 10.21
Fwd PE 8.61
P/S 1.39
P/FCF 19.26
P/OCF 11.83
P/B 1.59
P/tB 2.02
EV/EBITDA 9.06
EPS(TTM)6.09
EY9.8%
EPS(NY)7.22
Fwd EY11.62%
FCF(TTM)3.23
FCFY5.19%
OCF(TTM)5.25
OCFY8.45%
SpS44.79
BVpS38.97
TBVpS30.79
PEG (NY)1.58
PEG (5Y)2.78
Profitability
Industry RankSector Rank
ROA 1.14%
ROE 14.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 15.03%
PM (TTM) 12.55%
GM N/A
FCFM 7.2%
ROA(3y)1.08%
ROA(5y)1.01%
ROE(3y)14.33%
ROE(5y)11.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.35%
ROCE(5y)1.3%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y20.52%
OM growth 5Y15.89%
PM growth 3Y24.5%
PM growth 5Y12.46%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 7.4
Debt/EBITDA 2.88
Cap/Depr 130%
Cap/Sales 4.52%
Interest Coverage 4.55
Cash Conversion 63.37%
Profit Quality 57.42%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACC7.04%
ROIC/WACCN/A
Cap/Depr(3y)80.34%
Cap/Depr(5y)60.12%
Cap/Sales(3y)3.25%
Cap/Sales(5y)2.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.42%
EPS 3Y10.44%
EPS 5Y3.68%
EPS Q2Q%13.2%
EPS Next Y6.46%
EPS Next 2Y7.75%
EPS Next 3Y7.49%
EPS Next 5Y2.75%
Revenue 1Y (TTM)13.36%
Revenue growth 3Y-11.82%
Revenue growth 5Y-8.69%
Sales Q2Q%12.18%
Revenue Next Year10.24%
Revenue Next 2Y6.98%
Revenue Next 3Y6.13%
Revenue Next 5Y2.66%
EBIT growth 1Y-7.53%
EBIT growth 3Y6.27%
EBIT growth 5Y5.82%
EBIT Next Year-22.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y658.26%
FCF growth 3YN/A
FCF growth 5Y18.15%
OCF growth 1Y742.74%
OCF growth 3YN/A
OCF growth 5Y17.48%